Sort
78,016 grants matching “breast cancer”
TAMOXIFEN--RISK OF MI, STROKE AND VENOUS THROMBOEMBOLISM
$467,026University Of Southern California · R01 · FY2000 · CA
OCHSNER COMMUNITY CLINICAL ONCOLOGY PROGRAM
$467,005Ochsner Clinic Foundation · U10 · FY2002 · CA
Project 2: TMEJ Regulation in Cancer and Treatment Resistance
$466,907Gaorav P. Gupta · Univ Of North Carolina Chapel Hill · P01 · FY2025 · CA
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$466,898Xinna Zhang · Indiana University Indianapolis · R01 · FY2025 · CA
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$466,898Xinna Zhang · Indiana University Indianapolis · R01 · FY2023 · CA
Genetic Susceptibility And The Environment In Cancer Risk
$466,847Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
IBCSG Statistical Center - A Breast Cancer Study Resource
$466,815Meredith M Regan · Dana-Farber Cancer Inst · U24 · FY2014 · CA
UNIVERSITY OF PENNSYLVANIA CANCER GENETICS NETWORK
$466,783University Of Pennsylvania · U24 · FY2004 · CA
Genetics of Cognitive Decline Post Cancer Chemotherapy
$466,747Tim Alan Ahles · Dartmouth College · R01 · FY2006 · CA
DAXX AS A POTENTIAL BREAST CANCER ONCOGENE
$466,721Trustees Of The University Of Pennsylvania, The · · FY2008 · Department of Defense
Chemo-neoepitopes as novel immunotherapy for triple negative breast cancer
$466,702Pramod K. Srivastava · University Of Connecticut Sch Of Med/Dnt · R21 · FY2021 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2017 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2018 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2021 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2020 · CA
Dietary Methyl Content, Epigenetics and Breast Cancer
$466,673Jia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · CA
Discovery and Development of Cancer Glycomarkers
$466,670James Michael Pierce · University Of Georgia · U01 · FY2012 · CA
Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection
$466,655Lonie Salkowski · University Of Wisconsin-Madison · R37 · FY2022 · CA
CHARACTERISTICS OF LONG TERM BREAST CANCER SURVIVORS
$466,626Case Western Reserve University · R01 · FY2003 · CA
miRNA Expression Profiling
$466,613David M Brown · Ambion Diagnostics, Inc. · R44 · FY2007 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$466,587Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2024 · CA
TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients
$466,575Sanchita Bhatnagar · University Of California At Davis · R01 · FY2025 · CA
A Pathway of Tumor Suppression
$466,560Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
A Pathway of Tumor Suppression
$466,560Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
A Pathway of Tumor Suppression
$466,560Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA